2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors

被引:13
|
作者
Cai, Jiaqiang [1 ]
Bennett, D. Jonathan [1 ]
Rankovic, Zoran [1 ]
Dempster, Maureen [1 ]
Fradera, Xavier [1 ]
Gillespie, Jonathan [1 ]
Cumming, Iain [1 ]
Finlay, William [1 ]
Baugh, Mark [1 ]
Boucharens, Sylviane [1 ]
Bruin, John [1 ]
Cameron, Kenneth S. [1 ]
Hamilton, William [1 ]
Kerr, Jennifer [1 ]
Kinghorn, Emma [1 ]
McGarry, George [1 ]
Robinson, John [1 ]
Scullion, Paul [1 ]
Uitdehaag, Joost C. M. [2 ]
van Zeeland, Mario [2 ]
Potin, Dominique [3 ]
Saniere, Laurent [3 ]
Fouquet, Andre [3 ]
Chevallier, Francois [3 ]
Deronzier, Hortense [3 ]
Dorleans, Cecile [3 ]
Nicolai, Eric [3 ]
机构
[1] Merck Res Labs, MSD, Newhouse ML1 5SH, Lanark, Scotland
[2] Merck Res Labs, MSD, NL-5340 BH Oss, Netherlands
[3] Cerep, F-91951 Courtaboeuf, France
关键词
Cathepsin S; Transition state; Purine-6-carbonitrile; Lysosomotropism; K INHIBITORS; NEUROPATHIC PAIN; TARGET; 2-CYANO-PYRIMIDINES; DISCOVERY; REVERSAL; SCAFFOLD; SERIES;
D O I
10.1016/j.bmcl.2010.06.049
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Starting from previously disclosed equally potent cathepsin K and S inhibitor 4-propyl-6-(3-trifluoromethylphenyl) pyrimidine-2-carbonitrile 1, a novel 2-phenyl-9H-purine-6-carbonitrile scaffold was identified to provide potent and selective cathepsin S inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4447 / 4450
页数:4
相关论文
empty
未找到相关数据